Rosiglitazone Inhibits Bone Regeneration and Causes Significant Accumulation of Fat at Sites of New Bone Formation

Thiazolidinediones (TZDs), peroxisome proliferator-activated receptor gamma activators, and insulin sensitizers represent drugs used to treat hyperglycemia in diabetic patients. Type 2 diabetes mellitus (T2DM) is associated with a twofold increase in fracture risk, and TZDs use increases this risk b...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Liu, Lichu, Aronson, James, Huang, Shilong, Lu, Yalin, Czernik, Piotr, Rahman, Sima, Kolli, Vipula, Suva, Larry J., Lecka-Czernik, Beata
Formato: Artigo
Idioma:Inglês
Publicado em: 2012
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3630993/
https://ncbi.nlm.nih.gov/pubmed/22752619
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00223-012-9623-4
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados